15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 0.5% per year over the past 5 years.
Operating margin has expanded, at 6.4% in the latest year.
Financial health
Total debt ($939M) exceeds cash ($369M); net debt is $570M.
Total debt has grown slower than revenue (-28.4% vs -0.5% per year).
Operating income covered interest expense 2.8× in the latest year.
Total debt is 2.5× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$3.8B
$95M
25.3%
6.4%
—
$939M
$369M
2024
$3.8B
-$17M
24.5%
4.9%
—
$927M
$296M
2022
$3.5B
-$581M
21.9%
-6.1%
—
$2.6B
$307M
2021
$3.9B
-$79M
26.7%
3.5%
—
—
—
2020
$3.9B
-$269M
26.5%
0.6%
—
—
—
2019
$4.4B
-$341M
24.2%
-0.6%
—
—
$281M
2018
$4.6B
-$531M
19.6%
-7.1%
—
—
$458M
2017
$4.6B
-$242M
21.7%
-2.0%
—
—
$535M
2016
$3.3B
-$42M
21.5%
-5.1%
—
—
$653M
2015
—
$74M
—
—
—
—
$314M
2014
—
$114M
—
—
—
—
$326M
2013
—
-$182M
—
—
—
—
$231M
2012
—
$74M
—
—
—
—
$369M
2011
—
$144M
—
—
—
—
$334M
2010
—
-$20M
—
—
$222M
—
$329M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$892M
$5M
23.9%
3.7%
—
$939M
$359M
Dec '25
$1.1B
$50M
25.3%
7.5%
—
$939M
$369M
Sep '25
$945M
$41M
25.9%
7.8%
—
$934M
$246M
Jun '25
$915M
$12M
25.6%
6.1%
—
$931M
$279M
Mar '25
$841M
-$8M
24.1%
3.5%
—
$929M
$307M
Dec '24
$989M
$6M
23.4%
4.2%
—
$927M
$296M
Sep '24
$927M
-$22M
25.5%
5.0%
—
$1.1B
$251M
Jun '24
$940M
$15M
25.9%
7.5%
—
$1.1B
$277M
Mar '24
$895M
-$15M
23.3%
2.7%
—
$1.1B
$282M
Dec '23
$733M
$22M
30.5%
7.6%
—
$1.3B
$550M
Sep '23
$895M
-$9M
14.5%
4.1%
—
$1.3B
$376M
Jun '23
$922M
-$677M
24.4%
-0.4%
—
$2.2B
$505M
Mar '23
$858M
-$111M
24.4%
-0.2%
—
$2574
$235M
Dec '22
$969M
-$149M
22.4%
-4.4%
—
$2.6B
$307M
Sep '22
$810M
-$50M
23.9%
0.7%
—
—
$128M
Jun '22
$852M
-$199M
18.9%
-10.7%
—
—
—
Mar '22
$830M
-$183M
22.3%
-10.1%
—
—
—
Dec '21
$1.1B
-$38M
24.4%
4.7%
—
—
—
Sep '21
$958M
-$2M
27.1%
4.0%
—
—
—
Jun '21
$944M
-$30M
26.7%
1.4%
—
—
—
Valuation over time
How the market has priced DBD against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 24.9× (Dec '25) to 30.9× (Jun '26).
The price-to-sales ratio has risen from 0.0× (Mar '23) to 0.8× (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is DBD growing its revenue and profit?
Over the past 5 years, Diebold Nixdorf, Inc's revenue has declined 0.5% per year. These are computed facts, not advice.
How much debt does DBD have?
As of FY2025, Diebold Nixdorf, Inc reported $939M of total debt against $369M of cash; operating income covered interest expense 2.8×.
What is DBD's profit margin?
In FY2025, gross margin was 25.3%, operating margin 6.4%, and net margin 2.5%.
What is DBD's P/E ratio?
As of Jun '26, Diebold Nixdorf, Inc traded at a price-to-earnings ratio of about 30.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.